Research Topics
| Teri B PearlsteinSummaryAffiliation: Brown University Country: USA Publications
|
Detail Information
Publications
Psychotropic medications and other non-hormonal treatments for premenstrual disordersTeri Pearlstein
Alpert Medical School of Brown University, Providence, RI 02912, USA
Menopause Int 18:60-4. 2012..Anxiolytics, calcium, chasteberry and cognitive-behaviour therapy may also have a role in the treatment of premenstrual symptoms...
Perinatal depression: treatment options and dilemmasTeri Pearlstein
Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University and the Women s Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905, USA
J Psychiatry Neurosci 33:302-18. 2008....- Premenstrual dysphoric disorder: burden of illness and treatment updateTeri Pearlstein
Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University and Women s Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905, USA
J Psychiatry Neurosci 33:291-301. 2008..In addition, other hormones that suppress ovulation, anxiolytics, cognitive therapy, chasteberry and calcium may be helpful... 
Patient choice of treatment for postpartum depression: a pilot studyT B Pearlstein
Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI 02905, USA
Arch Womens Ment Health 9:303-8. 2006..The objective of this pilot trial was to examine the clinical characteristics of women with PPD associated with treatment selection...- Review of fluoxetine and its clinical applications in premenstrual dysphoric disorderTeri Pearlstein
Women s Behavioural Health Program, Women and Infants Hospital, 101 Dudley Street, Providence, RI 02905 2499, USA
Expert Opin Pharmacother 3:979-91. 2002..Fluoxetine is generally a well-tolerated treatment for PMDD and discontinuation effects have not been reported with intermittent dosing regimens... - Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulationTeri B Pearlstein
Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI 02905, USA
Contraception 72:414-21. 2005.... - Pretreatment pattern of symptom expression in premenstrual dysphoric disorderTeri Pearlstein
Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA
J Affect Disord 85:275-82. 2005..Use of intermittent dosing strategies for the treatment of premenstrual dysphoric disorder (PMDD) highlights the need for detailed empirical data on the onset, duration and pattern of symptom expression in women suffering from PMDD... - Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?Teri Pearlstein
Department of Psychiatry and Human Behavior, Brown Medical School, Providence, Rhode Island, USA
Drugs 62:1869-85. 2002..Future research needs to address less frequent dose administration regimens, such as 'symptom-onset' dose administration, and the recommended length of treatment... - Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatmentTeri Pearlstein
Women's Behavioral Health Program, Women and Infants Hospital, Providence, RI 02905-2499, USA
Am J Obstet Gynecol 188:887-95. 2003..The rapid recurrence of symptoms further supports the view of premenstrual dysphoric disorder as a clinical entity distinct from depression... - Depression and breastfeeding: which postpartum patients take antidepressant medications?Cynthia L Battle
Brown Medical School, Providence, Rhode Island, USA
Depress Anxiety 25:888-91. 2008..No differences were found in age, race, or education... - A preventive intervention for pregnant women on public assistance at risk for postpartum depressionCaron Zlotnick
Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, USA
Am J Psychiatry 163:1443-5. 2006..In this study, the authors examined whether the intervention would reduce the risk of postpartum major depressive disorder in a larger sample of pregnant women... - Clinical characteristics of perinatal psychiatric patients: a chart review studyCynthia L Battle
Brown Medical School, Department of Psychiatry and Human Behavior, Providence, Rhode Island, USA
J Nerv Ment Dis 194:369-77. 2006..For more than a third of the sample, the treatment sought while pregnant or postpartum represented their first contact with the mental health system. Treatment implications are discussed... - Postpartum depressionTeri Pearlstein
Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, RI, USA
Am J Obstet Gynecol 200:357-64. 2009..Further research is needed to examine systematically the short-term and long-term effect of medication exposure through breastmilk on infant and child development... - Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorderKimberly A Yonkers
Department of Psychiatry, Yale University, New Haven, Connecticut 06510, USA
Obstet Gynecol 106:492-501. 2005..To compare the efficacy of a new low-dose oral contraceptive pill (OCP) formulation with placebo in reducing symptoms of premenstrual dysphoric disorder... - Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategiesSusan G Kornstein
Virginia Commonwealth University School of Medicine, Richmond 23298 0710, USA
J Clin Psychiatry 67:1624-32. 2006....